ArticleInternal medicine (Tokyo, Japan)2026
Multiple Elective Surgeries and Cord Blood Transplantation for Multi-refractory Monomorphic Epitheliotropic Intestinal T-cell Lymphoma.
Article in Internal medicine (Tokyo, Japan), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 42-year-old woman was diagnosed with monomorphic epithelial-type intestinal T-cell lymphoma (MEITL) following small bowel endoscopy. The patient subsequently underwent a small bowel resection to prevent perforation. Bowel lesions progressed shortly after completion of first-line chemotherapy. Although four different salvage regimens were attempted, they were refractory, and both bowel and ovarian lesions progressed. Partial jejunal resection was performed during the fifth salvage regimen, followed by oophorectomy. After achieving complete remission, she underwent cord blood transplantation and remained alive 37 months after the diagnosis. Integration of elective surgery and allogeneic transplantation may be a treatment option for relapsed or refractory MEITL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.